BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kanji ZS, Gallinger S. Diagnosis and management of pancreatic cancer. CMAJ. 2013;185:1219-1226. [PMID: 23610017 DOI: 10.1503/cmaj.121368] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 2.9] [Reference Citation Analysis]
Number Citing Articles
1 Qin RF, Zhang J, Huo HR, Yuan ZJ, Xue JD. MiR-205 mediated APC regulation contributes to pancreatic cancer cell proliferation. World J Gastroenterol 2019; 25(28): 3775-3786 [PMID: 31391772 DOI: 10.3748/wjg.v25.i28.3775] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
2 Li F, Zhang P, Wu S, Yuan L, Liu Z. Advance in Human Epithelial-Derived Organoids Research. Mol Pharm 2021;18:3931-50. [PMID: 34582198 DOI: 10.1021/acs.molpharmaceut.1c00452] [Reference Citation Analysis]
3 Singh S, McDonald JT, Ilie G, Adisesh A. An examination of the association between lifetime history of prostate and pancreatic cancer diagnosis and occupation in a population sample of Canadians. PLoS One 2020;15:e0227622. [PMID: 32023280 DOI: 10.1371/journal.pone.0227622] [Reference Citation Analysis]
4 Grant RC, Selander I, Connor AA, Selvarajah S, Borgida A, Briollais L, Petersen GM, Lerner-Ellis J, Holter S, Gallinger S. Prevalence of germline mutations in cancer predisposition genes in patients with pancreatic cancer. Gastroenterology 2015;148:556-64. [PMID: 25479140 DOI: 10.1053/j.gastro.2014.11.042] [Cited by in Crossref: 177] [Cited by in F6Publishing: 162] [Article Influence: 25.3] [Reference Citation Analysis]
5 Roy BT, Roy RB. Metastatic pancreatic cancer: abdominal pain in a 22-year-old woman. BMJ Case Rep 2015;2015:bcr2015211361. [PMID: 26611479 DOI: 10.1136/bcr-2015-211361] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
6 Fontana G, Riboldi M, Gianoli C, Chirvase CI, Villa G, Paganelli C, Summers PE, Tagaste B, Pella A, Fossati P, Ciocca M, Baroni G, Valvo F, Orecchia R. MRI quantification of pancreas motion as a function of patient setup for particle therapy -a preliminary study. J Appl Clin Med Phys 2016;17:60-75. [PMID: 27685119 DOI: 10.1120/jacmp.v17i5.6236] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
7 Karakas Y, Lacin S, Yalcin S. Recent advances in the management of pancreatic adenocarcinoma. Expert Review of Anticancer Therapy 2018;18:51-62. [DOI: 10.1080/14737140.2018.1403319] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
8 Wuebben EL, Wilder PJ, Cox JL, Grunkemeyer JA, Caffrey T, Hollingsworth MA, Rizzino A. SOX2 functions as a molecular rheostat to control the growth, tumorigenicity and drug responses of pancreatic ductal adenocarcinoma cells. Oncotarget 2016;7:34890-906. [PMID: 27145457 DOI: 10.18632/oncotarget.8994] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
9 Xu Y, Liu P, Zheng DH, Wu N, Zhu L, Xing C, Zhu J. Expression profile and prognostic value of NNMT in patients with pancreatic cancer. Oncotarget 2016;7:19975-81. [PMID: 26942567 DOI: 10.18632/oncotarget.7891] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 4.7] [Reference Citation Analysis]
10 Connor AA, Gallinger S. Hereditary Pancreatic Cancer Syndromes. Surg Oncol Clin N Am. 2015;24:733-764. [PMID: 26363539 DOI: 10.1016/j.soc.2015.06.007] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 3.8] [Reference Citation Analysis]
11 Laitinen I, Sand J, Peromaa P, Nordback I, Laukkarinen J. Quality of life in patients with pancreatic ductal adenocarcinoma undergoing pancreaticoduodenectomy. Pancreatology 2017;17:445-50. [DOI: 10.1016/j.pan.2017.02.013] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
12 Ahmed O, Lee JH. Preoperative biliary drainage for pancreatic cancer. Gastrointestinal Intervention 2018;7:67-73. [DOI: 10.18528/gii180017] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
13 Hyde AJ, Nassabein R, AlShareef A, Armstrong D, Babak S, Berry S, Bossé D, Chen E, Colwell B, Essery C, Goel R, Goodwin R, Gray S, Hammad N, Jeyakuymar A, Jonker D, Karanicolas P, Lamond N, Letourneau R, Michael J, Patil N, Powell E, Ramjeesingh R, Saliba W, Singh R, Snow S, Stuckless T, Tadros S, Tehfé M, Thana M, Thirlwell M, Vickers M, Virik K, Welch S, Asmis T. Eastern Canadian Gastrointestinal Cancer Consensus Conference 2018. Curr Oncol 2019;26:e665-81. [PMID: 31708660 DOI: 10.3747/co.26.5193] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Mamun MA, Mannoor K, Cao J, Qadri F, Song X. SOX2 in cancer stemness: tumor malignancy and therapeutic potentials. J Mol Cell Biol 2020;12:85-98. [PMID: 30517668 DOI: 10.1093/jmcb/mjy080] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 17.0] [Reference Citation Analysis]
15 O'Kane GM, Ladak F, Gallinger S. Advances in the management of pancreatic ductal adenocarcinoma. CMAJ 2021;193:E844-51. [PMID: 34099468 DOI: 10.1503/cmaj.201450] [Reference Citation Analysis]
16 Hu C, LaDuca H, Shimelis H, Polley EC, Lilyquist J, Hart SN, Na J, Thomas A, Lee KY, Davis BT, Black MH, Pesaran T, Goldgar DE, Dolinsky JS, Couch FJ. Multigene Hereditary Cancer Panels Reveal High-Risk Pancreatic Cancer Susceptibility Genes. JCO Precis Oncol 2018;2. [PMID: 31497750 DOI: 10.1200/PO.17.00291] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
17 Hu C, Hart SN, Bamlet WR, Moore RM, Nandakumar K, Eckloff BW, Lee YK, Petersen GM, McWilliams RR, Couch FJ. Prevalence of Pathogenic Mutations in Cancer Predisposition Genes among Pancreatic Cancer Patients. Cancer Epidemiol Biomarkers Prev 2016;25:207-11. [PMID: 26483394 DOI: 10.1158/1055-9965.EPI-15-0455] [Cited by in Crossref: 81] [Cited by in F6Publishing: 44] [Article Influence: 13.5] [Reference Citation Analysis]
18 Huang L, Holtzinger A, Jagan I, BeGora M, Lohse I, Ngai N, Nostro C, Wang R, Muthuswamy LB, Crawford HC, Arrowsmith C, Kalloger SE, Renouf DJ, Connor AA, Cleary S, Schaeffer DF, Roehrl M, Tsao MS, Gallinger S, Keller G, Muthuswamy SK. Ductal pancreatic cancer modeling and drug screening using human pluripotent stem cell- and patient-derived tumor organoids. Nat Med. 2015;21:1364-1371. [PMID: 26501191 DOI: 10.1038/nm.3973] [Cited by in Crossref: 321] [Cited by in F6Publishing: 308] [Article Influence: 53.5] [Reference Citation Analysis]
19 Tong E, Lo C, Moura S, Antes K, Buchanan S, Kamtapersaud V, Devins GM, Zimmermann C, Gallinger S, Rodin G. Development of a psychoeducational intervention for people affected by pancreatic cancer. Pilot Feasibility Stud 2019;5:80. [PMID: 31245024 DOI: 10.1186/s40814-019-0466-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
20 Arts HH, Lynch L, Grafodatskaya D, Eng B, Malloy L, Duck J, White R, Woodside C, Bell K, Zbuk KM, McCready E. ATM whole gene deletion in an Italian family with hereditary pancreatic cancer: Challenges to cancer risk prediction associated with an 11q22.3 microdeletion. Cancer Genet 2020;240:1-4. [PMID: 31671381 DOI: 10.1016/j.cancergen.2019.10.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
21 Kwon CI. [Relief of Obstruction in the Management of Pancreatic Cancer]. Korean J Gastroenterol 2019;74:69-80. [PMID: 31438658 DOI: 10.4166/kjg.2019.74.2.69] [Reference Citation Analysis]
22 Yu LM, Zhu YS, Xu CZ, Zhou LL, Xue ZX, Cai ZZ. High calpain-1 expression predicts a poor clinical outcome and contributes to tumor progression in pancreatic cancer patients. Clin Transl Oncol 2019;21:924-32. [PMID: 30565085 DOI: 10.1007/s12094-018-02006-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]